In type IV TIME, there is a substantial number of M2 macrophages that can be switched to the M1 phenotype in order to reduce the tumor growth and also high TILs; however, the PD-1/PD-L1 axis cannot be targeted and other immunosuppressive pathways not yet well known should be addressed in the future [7]. Here, PDCD1 is linked to neoplasm.